- Home
- GOTU vs TRVI Comparison
GOTU vs TRVI Comparison
Compare GOTU & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOTU
- TRVI
- Stock Information
- Founded
- GOTU 2014
- TRVI 2011
- Country
- GOTU China
- TRVI United States
- Employees
- GOTU N/A
- TRVI N/A
- Industry
- GOTU Other Consumer Services
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- GOTU Real Estate
- TRVI Health Care
- Exchange
- GOTU Nasdaq
- TRVI Nasdaq
- Market Cap
- GOTU 559.5M
- TRVI 629.8M
- IPO Year
- GOTU 2019
- TRVI 2019
- Fundamental
- Price
- GOTU $3.82
- TRVI $5.95
- Analyst Decision
- GOTU Strong Buy
- TRVI Strong Buy
- Analyst Count
- GOTU 1
- TRVI 8
- Target Price
- GOTU $5.81
- TRVI $19.31
- AVG Volume (30 Days)
- GOTU 1.8M
- TRVI 1.6M
- Earning Date
- GOTU 05-15-2025
- TRVI 05-08-2025
- Dividend Yield
- GOTU N/A
- TRVI N/A
- EPS Growth
- GOTU N/A
- TRVI N/A
- EPS
- GOTU N/A
- TRVI N/A
- Revenue
- GOTU $702,778,750.00
- TRVI N/A
- Revenue This Year
- GOTU $31.85
- TRVI N/A
- Revenue Next Year
- GOTU $24.83
- TRVI N/A
- P/E Ratio
- GOTU N/A
- TRVI N/A
- Revenue Growth
- GOTU 59.35
- TRVI N/A
- 52 Week Low
- GOTU $1.87
- TRVI $2.30
- 52 Week High
- GOTU $5.96
- TRVI $7.48
- Technical
- Relative Strength Index (RSI)
- GOTU 62.51
- TRVI 41.89
- Support Level
- GOTU $3.57
- TRVI $6.08
- Resistance Level
- GOTU $3.87
- TRVI $7.48
- Average True Range (ATR)
- GOTU 0.19
- TRVI 0.48
- MACD
- GOTU -0.01
- TRVI -0.04
- Stochastic Oscillator
- GOTU 24.75
- TRVI 27.14
About GOTU Gaotu Techedu Inc.
Gaotu Techedu Inc is a technology-driven education company that provides online live courses in a large-class setting backed by its proprietary technology infrastructure. The company's segment includes the provision of education services. The company offers courses in large-class format, which amplifies the benefits of online education and allows it to rapidly expand its student base. It operates solely in the PRC and all assets are located in the PRC. The learning services that the company offers include Traditional Learning Services, Non-Academic Tutoring Services, and College Student and Adult Education Services.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.